Please click on the links to below to learn more about the clinical studies & trials currently underway. If you would like to participate in any of these trials, please contact the listed study coordinator.
CAPTURE: Collaborative Assessment of Pediatric Transverse myelitis; Understand, Reveal, Educate Principal Investigator: Benjamin Greenberg, MD, MHS University of Texas Southwestern/Childrens Medical Center, Dallas, TX ClinicalTrials.gov Identifier: NCT02144935 Efficacy and Safety Study as Monotherapy of SA237 to Treat NMO and NMOSD Sponsor: Chugai Pharmaceuticals The PREVENT Study Study Sponsor: Alexion Pharmaceuticals Spinal Cord MRI Research Study for Children, Adolescents, and Young Adults with Transverse Myelitis Principal Investigator: Nadia Barakat, PhD Study Site: Boston Children’s Hospital An open-label study of bevacizumab for the treatment of acute optic neuritis and/or transverse myelitis in neuromyelitis optica and neuromyelitis optica spectrum disorder Investigator: Michael Levy, MD, PhD Study Site: Johns Hopkins University, Baltimore, MD A Safety, Tolerability and Efficacy Study of V158866 in Central Neuropathic Pain Following Spinal Cord Injury Investigator: Christine N. Sang, MD, MPH Study Site: Brigham and Women’s Hospital, Boston, MA
Safety and Efficacy of Sustained release Dalfampridine in Transverse Myelitis Investigator: Michael Levy, MD, PhD Study Site: Johns Hopkins University, Baltimore, MD Collaborator: Acorda Therapeutics
A Longitudinal Study of Neuromyelitis Optica and Transverse Myelitis Investigator: Benjamin Greenberg, MD, MHS University of Texas Southwestern Medical Center, Dallas, TX
The Effect of Pregnancy on Neuromyelitis Optica Investigator: Eric Klawiter, MD Massachusetts General Hospital, Harvard Medical School, Boston, MA
FES Impact on CNS Growth Factors in TM, NMO and other, Neuroinflammatory Disorders Investigator: Daniel Becker, MD Hugo W. Moser Research Institute at Kennedy Krieger, Baltimore, MD Neuroimaging and Neurobehavioral Outcomes of Pediatric Neuromyelitis Optica: A Pilot Study Investigator: Ana Arenivas, Ph.D. Johns Hopkins Medicine, Baltimore, MD